SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

SUN PHARMA ADVANCED RESEARCH C

BSE: 532872 19 Aug 2025
Healthcare
₹ 147.6
Sun Pharma Advanced Research Company Ltd. specializes in Pharmaceuticals within the Healthcare sector.

SUN PHARMA ADVANCED RESEARCH C - Share Price & Details

Market Cap
₹5,384
High /Low
258.0 / 109.0
Stock P/E
NA
Book Value
₹-6.8
Dividend Yield
0.0
ROCE
-298.0
ROE
₹NA
Face Value
1.0
PEG Ratio
NA
EVEBITDA
₹-17.4
Debt
265
CMP / FCF
-17.7
Debt to equity
₹0.45
NP Ann
-345
High price all time
594.0
Piotroski score
₹2.0
Graham Number
NA
No. Eq. Shares
32.4
Net CF
₹-3.87
Net profit
-345
Price to book value
NA
Interest Coverage
₹-37.8
Low price all time
35.2
Industry PE
33.8
Reserves
₹-253
Free Cash Flow
₹-372

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
Shyama Computronics and Servic1.480.930.670.005.3335.5
Triochem Products Ltd.,3.25-4.52NA-18.440
SUN PHARMA ADVANCED RESEARCH C187.8-518.796.4-1.65,384
SUVEN LIFE SCIENCES LTD.24.56-147.7918.67-0.685147
AARTI DRUGS LTD.5213.4486.45209.65.33457824.2

Peer Comparison Chart


About SUN PHARMA ADVANCED RESEARCH C

Sun Pharma Advanced Research Company Ltd., with Security Code 532872, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Latest News

Sun Pharma Advanced Research Company Limited (532872) Gets Regulatory Approval - Phenomenal returns

(24 Jul 2025)
Sun Pharma Advanced Research Company Limited (532872) Gets Regulatory Approval ✌️【Trading Ideas】✌️ Our platform integrates global futures,...
Read more →

Macro Trends and Their Impact on Sun Pharma Advanced Research Company Limited (532872) - Unmatched market performance

(23 Jul 2025)
Macro Trends and Their Impact on Sun Pharma Advanced Research Company Limited (532872) ✌️【Market Focus】✌️ Imagine turning a $1,000...
Read more →

SPARC incorporates subsidiary ‘Genokine Biotech’

(14 Jul 2025)
Sun Pharma Advanced Research Company (SPARC) has incorporated a wholly owned subsidiary Genokine Biotech Limited with registered office in Vadodara, Gujarat.
Read more →

SPARC Confirms Pipeline Strength, No Capex Plans After Psoriasis Drug Setback — Profit Exclusive

(24 Jun 2025)
Sun Pharma Advanced Research Co. has told NDTV Profit that it expects no financial impact or need for fresh capital expenditure following...
Read more →

Sun Pharma Advanced Research shares tank 20% after psoriasis drug fails Phase 2 trials

(10 Jun 2025)
Sun Pharma Advanced Research Company (SPARC) psoriasis drug, Vibozilimod (SCD-044), failed to meet primary endpoints in Phase 2 trials for psoriasis and...
Read more →

Sun Pharma Advanced Research hits 20% lower band; what's rattling Street?

(08 Jun 2025)
Sun Pharma Advanced Research Company (SPARC) shares slumped 20 per cent in trade on Wednesday, June 4, 2025, hitting its lower circuit at...
Read more →

Company Updates